Related Experiment Video

Updated: Jun 19, 2026

An Intact Pericardium Ischemic Rodent Model
07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

Diagnosis and management of pericardial diseases

Massimo Imazio1, Antonio Brucato, Rita Trinchero

  • 1Cardiology Department, Maria Vittoria Hospital, Torino, Italy. massimo_imazio@yahoo.it

Nature Reviews. Cardiology
|October 28, 2009
PubMed

Insights

Managing pericardial diseases is becoming more evidence-based, especially for pericarditis. Emerging data allows for tailored patient treatment and guides management strategies, though optimal duration remains unclear.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Clinical Practice Guidelines

Background:

  • Management of pericardial diseases lacks robust evidence due to limited randomized trials.
  • The first guidelines for pericardial disease management have been published.
  • Recent studies are shifting the field towards evidence-based medicine.

Purpose of the Study:

  • To organize current knowledge on pericardial disease management.
  • To highlight the transition towards evidence-based practice in cardiology.
  • To provide guidance for managing and following up on pericardial diseases.

Main Methods:

  • Review of observational studies and randomized trials.
  • Synthesis of existing literature and guideline recommendations.
  • Analysis of emerging data for personalized treatment approaches.

Main Results:

  • Evidence base for pericardial disease management is growing, particularly for pericarditis.
  • Individualized patient management strategies are becoming feasible.
  • Recommendations for management and follow-up can be formulated despite undefined optimal treatment duration.

Conclusions:

  • Pericardial disease management is evolving from empirical to evidence-based approaches.
  • Tailored treatment plans are crucial for effective patient care.
  • Further research is needed to establish optimal treatment durations.

More Related Videos

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

Related Concept Videos

Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...